Dr. Anjali Vaidya Provides Perspective to Healio on FDA Label Update for Winrevair 

Anjali Vaidya, MD, Director of the Advanced Pulmonary Hypertension, Right Heart Failure & CTEPH Program at Temple University Hospital, provided perspective to Healio on the FDA approving a label update for Winrevair to include that it lowers the risk for clinical worsening events in adults with recently diagnosed pulmonary arterial hypertension.